MarketPeel
Insider Trading Intelligence
RT

Renee P. Tannenbaum

CRDF
DIRECTOR · CARDIFF ONCOLOGY, INC. · CIK 0001543174
FILING MIX · LIFETIME88%/12%
BUYS
14
SELLS
2
TOTAL VALUE
$325.2K
COMPANIES
2
ACTIVE SINCE
Jun 2021
HOLDINGS NOW
238,845
AVG SELL PX
$72.06
TRADE KIND
SHOWING 16 / 16
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
5 backtested trades · 8 horizons · 3 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Renee P. Tannenbaum, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d5+60.00%+5.34%-2.29%+7.63%+1.88%
14d5+40.00%+3.60%-3.06%+6.66%+0.66%
30d5+60.00%-2.16%-3.31%+1.16%+0.17%
60d5+60.00%-1.49%+2.19%-3.67%-7.42%
90d5+60.00%-3.79%+0.19%-3.97%-10.35%
180d5+100.00%+6.35%+4.16%+5.33%+4.10%
1y5(1 pending)+75.00%-6.41%+14.80%-21.21%-16.04%
2y5(2 pending)+66.67%+50.17%+46.37%+3.79%+13.81%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
CRDF · 209,331 shares · as of Jun 11, 2026
052,333104,666156,998209,33120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 14 buys / 2 sellsCOVERAGE · 21 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
CRDF
CARDIFF ONCOLOGY, INC.
PURCHASEGRANT
Stock grant
40,565209,331Jun 11, 2026Jun 15, 2026View →
ANIP
ANI PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
4,35729,514May 21, 2026Jun 10, 2026View →
ANIP
ANI PHARMACEUTICALS INC
SALE
1,800$81.15$146.1K25,157Dec 5, 2025Dec 9, 2025View →
CRDF
CARDIFF ONCOLOGY, INC.
PURCHASEGRANT
Stock grant
40,565168,766Jun 26, 2025Jun 30, 2025View →
ANIP
ANI PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
4,33626,957May 22, 2025May 27, 2025View →
CRDF
CARDIFF ONCOLOGY, INC.
PURCHASE
10,000$3.42$34.2K20,000Dec 12, 2024Dec 16, 2024View →
CRDF
CARDIFF ONCOLOGY, INC.
PURCHASEGRANT
Stock grant
29,700128,201Jun 27, 2024Jul 1, 2024View →
ANIP
ANI PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
4,41022,621May 21, 2024May 23, 2024View →
ANIP
ANI PHARMACEUTICALS INC
SALE
2,000$63.87$127.7K18,211May 16, 2024May 17, 2024View →
CRDF
CARDIFF ONCOLOGY, INC.
PURCHASEGRANT
Stock grant
27,70098,501Jun 15, 2023Jun 20, 2023View →
ANIP
ANI PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
6,86520,211May 23, 2023May 24, 2023View →
CRDF
CARDIFF ONCOLOGY, INC.
PURCHASE
3,600$1.72$6.2K10,000Sep 15, 2022Sep 19, 2022View →
CRDF
CARDIFF ONCOLOGY, INC.
PURCHASE
6,400$1.72$11.0K6,400Sep 15, 2022Sep 19, 2022View →
ANIP
ANI PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
13,34613,346Mar 19, 2022Mar 22, 2022View →
CRDF
CARDIFF ONCOLOGY, INC.
PURCHASEGRANT
Stock grant
26,80070,801Mar 9, 2022Mar 10, 2022View →
CRDF
CARDIFF ONCOLOGY, INC.
PURCHASEGRANT
Stock grant
44,00144,001Jun 10, 2021Jun 14, 2021View →
Other insiders · CRDF
Loading peer insiders…
About this filer
CIK 0001543174
ROLE
Director
PRIMARY
CRDF
COMPANIES
2
ACTIVE SINCE
Jun 2021
MARKETPEEL · /INSIDER/0001543174DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback